Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
SlideShare a Scribd company logo
Earnings release

1Q08
May 16, 2008
ABOUT
TEMPO PARTICIPAÇÕES
Business segments




    Healthcare Administration      Dental HMO
                                                                    Assistance Services
    Services
                                   Ranking: #4
                                                                    Ranking: #1
    Ranking: #1
                                   Number of lives: 501 thousand
                                                                    Number of items: 18.6 million
    Number of lives: 1.3 million
                                   Underwriting of frequency risk
                                                                    Underwriting of frequency risk
    No underwriting risk. Fee
    business only.




3
Recent events

    Acquisition of Fleming Odontologia


    Assist-Card Joint Venture


    Approval for OdontoEmpresa transaction


    INFRAERO health contract


    1Q08 results: Adjusted EBITDA +34% and Revenues + 25%


    Additional purchase of shares from current shareholders




4
FINANCIAL AND OPERATING
PERFORMANCE
Tempo experienced a 34% increase in Adjusted EBITDA and a
            25% increase in net revenues for 1Q08

     Net Revenues - Tempo        Adjusted EBITDA - Tempo
                                                                    EBITDA margin - Tempo
            (R$ MM)                      (R$ MM)
                                                                            (% )


                  5%                                                              . p.
             +2                                  %
                                                                              ,6 p
                                                            10,0%                               0,6 p.p.
                                            ,0
                                         34                                 0
                                                            9,0%
                                                                                                0,5 p.p.
                                                            8,0%
                                                            7,0%                                0,4 p.p.
                                                            6,0%
                                                     13,4
                       160,1                                5,0%                                0,3 p.p.

                                                                                         8,4%
    128,0                         10,0                              7,8%
                                                            4,0%
                                                                                                0,2 p.p.
                                                            3,0%
                                                            2,0%
                                                                                                0,1 p.p.
                                                             1,0%
                                                            0,0%                                0,0 p.p.



    1Q07               1Q08       1Q07               1Q08           1Q07                 1Q08

        Revenues: solid increase in number of beneficiaries/items for all three
        segments
        Adjusted EBITDA: fixed costs dilution
        Results presented above do not comprise the acquisitions made in the
        end of 2007



6
Health
                                               Adjusted EBITDA (R$ MM)
    Beneficiaries (in millions)

                                  %
                            5,9
                       +2
                                                   10,0                                            10%
                                                                                       7,0%
                                                          5,0%
                                                   9,0
                                                                                                   0%
                                                   8,0
                                                   7,0
                                                                                                   -10%
                                                                               %
                                                   6,0
                                                                            97
                                       1,34        5,0                                             -20%
                                                   4,0
               1,06                                                                  6,7           -30%
                                                   3,0
                                                   2,0
                                                                    3,4                            -40%
                                                    1,0
                                                   0,0                                             -50%


                                                                   1Q07             1Q08
              mar/07                  mar/08


    Revenues (R$ MM)                                             Adjusted EBITDA   EBITDA margin

                                        95,9
                                                   25,9% increase in number of beneficiaries
                               ,6%
                           1
                        +4
                67,8                               41,6% increase in net revenues (including Med-Lar)
                                                   EBITDA: nominal and marginal increase




                1Q07                    1Q08
7
Dental
                                             Adjusted EBITDA (R$ MM)
    Beneficiaries (in thousands)

                                     501,1
                  403,1




                                                                         3%
                                                                        12
          143,1
                                                                                  4,1


                                                              1,8
             1Q07                 1Q08
              Gama odonto       Pro-forma
                                                             1Q07                1Q08
    Revenues R$ (MM)



                                               Information presented in this slide comprise the
                                               companies acquired in the end of 2007
                           3%
                          19




                                               Organic and acquisition        growth    in number of
                                               beneficiaries
                                    15,3
                                               Sustainable EBITDA margin
                  5,2                          Decrease in loss ratio

              1Q07                  1Q08

8
Assistance services
                                                   Adjusted EBITDA
    Loss ratio curve

                                                       10,0                                     10,0%
                                           50,4%                                         9,4%
                                                        9,0
            50,4%                                                                               9,0%
                                                              8,8%
                                                        8,0
                                                        7,0
                                                                                                8,0%
                                                        6,0
                                                                           14%
                                                        5,0                                     7,0%
                                                        4,0
                                                                                                6,0%
                                                                                   5,5
                                                        3,0
                                                                 4,8
                                                        2,0
                                                                                                5,0%
                    47,1%                               1,0
                                  45,9%                 0,0                                     4,0%


                                                                1Q07               1Q08

           1Q07      2Q07        3Q07      4Q07                        Adjusted EBITDA
                                                                       EBITDA margin
    Number of items (in millions)


                                                       Higher loss ratios for 1Q and 4Q
                             %
                     + 7,3
                                                       Capture of synergies after integrating USS
                                                       Potential increase in B2B2C sales
                                  18,6
             17,3                                      Assist Card Joint Venture




            mar/07                mar/08

9
Asset light operation
     Capex vs Adjusted EBITDA Pro-Forma (R$ mm)




                              CAPEX compared to Adjusted EBITDA (R$ MM)
                          31%                                  55,0
                                                   11%                9%
                                       8%                                      6%
                                                  37,6
                                   30,2


                 14,0                                                       13,4
                                                                      5,1
                        4,3                              4,0
                                          2,5                                      0,8

                   2004              2005          2006         2007        mar/08

                              Adjuested EBITDA       CAPEX      % of Adj. EBITDA




10
Investors Relations

 Phone: +55 11 4208-8069
E-mail: ri@tempopar.com.br
  www.tempopar.com.br/ri

More Related Content

1Q08 Results Conference Call Presentation

  • 3. Business segments Healthcare Administration Dental HMO Assistance Services Services Ranking: #4 Ranking: #1 Ranking: #1 Number of lives: 501 thousand Number of items: 18.6 million Number of lives: 1.3 million Underwriting of frequency risk Underwriting of frequency risk No underwriting risk. Fee business only. 3
  • 4. Recent events Acquisition of Fleming Odontologia Assist-Card Joint Venture Approval for OdontoEmpresa transaction INFRAERO health contract 1Q08 results: Adjusted EBITDA +34% and Revenues + 25% Additional purchase of shares from current shareholders 4
  • 6. Tempo experienced a 34% increase in Adjusted EBITDA and a 25% increase in net revenues for 1Q08 Net Revenues - Tempo Adjusted EBITDA - Tempo EBITDA margin - Tempo (R$ MM) (R$ MM) (% ) 5% . p. +2 % ,6 p 10,0% 0,6 p.p. ,0 34 0 9,0% 0,5 p.p. 8,0% 7,0% 0,4 p.p. 6,0% 13,4 160,1 5,0% 0,3 p.p. 8,4% 128,0 10,0 7,8% 4,0% 0,2 p.p. 3,0% 2,0% 0,1 p.p. 1,0% 0,0% 0,0 p.p. 1Q07 1Q08 1Q07 1Q08 1Q07 1Q08 Revenues: solid increase in number of beneficiaries/items for all three segments Adjusted EBITDA: fixed costs dilution Results presented above do not comprise the acquisitions made in the end of 2007 6
  • 7. Health Adjusted EBITDA (R$ MM) Beneficiaries (in millions) % 5,9 +2 10,0 10% 7,0% 5,0% 9,0 0% 8,0 7,0 -10% % 6,0 97 1,34 5,0 -20% 4,0 1,06 6,7 -30% 3,0 2,0 3,4 -40% 1,0 0,0 -50% 1Q07 1Q08 mar/07 mar/08 Revenues (R$ MM) Adjusted EBITDA EBITDA margin 95,9 25,9% increase in number of beneficiaries ,6% 1 +4 67,8 41,6% increase in net revenues (including Med-Lar) EBITDA: nominal and marginal increase 1Q07 1Q08 7
  • 8. Dental Adjusted EBITDA (R$ MM) Beneficiaries (in thousands) 501,1 403,1 3% 12 143,1 4,1 1,8 1Q07 1Q08 Gama odonto Pro-forma 1Q07 1Q08 Revenues R$ (MM) Information presented in this slide comprise the companies acquired in the end of 2007 3% 19 Organic and acquisition growth in number of beneficiaries 15,3 Sustainable EBITDA margin 5,2 Decrease in loss ratio 1Q07 1Q08 8
  • 9. Assistance services Adjusted EBITDA Loss ratio curve 10,0 10,0% 50,4% 9,4% 9,0 50,4% 9,0% 8,8% 8,0 7,0 8,0% 6,0 14% 5,0 7,0% 4,0 6,0% 5,5 3,0 4,8 2,0 5,0% 47,1% 1,0 45,9% 0,0 4,0% 1Q07 1Q08 1Q07 2Q07 3Q07 4Q07 Adjusted EBITDA EBITDA margin Number of items (in millions) Higher loss ratios for 1Q and 4Q % + 7,3 Capture of synergies after integrating USS Potential increase in B2B2C sales 18,6 17,3 Assist Card Joint Venture mar/07 mar/08 9
  • 10. Asset light operation Capex vs Adjusted EBITDA Pro-Forma (R$ mm) CAPEX compared to Adjusted EBITDA (R$ MM) 31% 55,0 11% 9% 8% 6% 37,6 30,2 14,0 13,4 5,1 4,3 4,0 2,5 0,8 2004 2005 2006 2007 mar/08 Adjuested EBITDA CAPEX % of Adj. EBITDA 10
  • 11. Investors Relations Phone: +55 11 4208-8069 E-mail: ri@tempopar.com.br www.tempopar.com.br/ri